Will George Church reverse aging │ Dr. George Church
Get the full length version of this episode as a podcast.
This episode will make a great companion for a long drive.
The BDNF Protocol Guide
An essential checklist for cognitive longevity — filled with specific exercise, heat stress, and omega-3 protocols for boosting BDNF. Enter your email, and we'll deliver it straight to your inbox.
Is aging just the accumulation of damage over time or is it a program that goes wrong? Using Yamanaka transcription factors, geneticists are able to reverse the aging program and take an adult cell back to a stem cell. This method of cell rejuvenation may change the way we treat disease and injury in the future.
In his recent research, Dr. Church has identified that the genes alpha-Klotho, FGF21, and TGF-beta1 can be used to rejuvenate older mice back to a healthier state. Next, Dr. Church plans to investigate the safety and efficacy of these factors in dogs, as they are large mammals like us and share our environment. Eventually, these animal models will inform how we use this cell therapy to reverse aging in humans. In this clip, Dr. George Church discusses how aging might be reversed and what research in animals can tell us about human aging.
This transcript is reserved for members.
FoundMyFitness Members get access to exclusive content not available anywhere else, including a transcript of this episode.
You wouldn't believe how cool being a premium member of the world's best cross-disciplinary science-focused website and podcast really is.
Member only extras:
Learn more about the advantages of a premium membership by clicking below.
Attend Monthly Q&As with Rhonda
Support our work
The FoundMyFitness Q&A happens monthly for premium members. Attend live or listen in our exclusive member-only podcast The Aliquot.
Genetic engineering News
- Vitamin B12 supports metabolic processes involved in stem cell reprogramming and tissue repair.
- Ovarian cancer tumors, even at advanced stages, may be effectively targeted and eliminated by CAR-T immune therapies, a new study in mice suggests.
- ‘Gene silencing’ therapy reduces lipoprotein(a), an important risk factor of heart disease, by up to 98%
- Gene therapy for thalassemia ends need for transfusions in young children
- Designer cytokine restores spinal cord function in mice.
